ALSSI SuperSonic Imagine SA

SuperSonic Imagine Installs 13 Aixplorer MACH® 30 Systems in Israel

SuperSonic Imagine Installs 13 Aixplorer MACH® 30 Systems in Israel

  • Sale and installation of 13 Aixplorer MACH® 30 ultrasound systems in the Clalit network: leader of Israeli health insurance organisation
  • Use of ultrasound systems in senology, gastroenterology and mainstream medicine for medical imaging

AIX-EN-PROVENCE, France, Jan. 24, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialising in ultrasound medical imaging, today announced the installation of 13 Aixplorer MACH® 30 systems, the new, smart and leading edge ultrasound platform, in Clalit’s network which is the first health insurance organisation in Israel, with 52.5% of the population as members.

Israel is one of the most innovative global hubs when it comes to technology around health. The Clalit health insurance organisation, a long-time client of SuperSonic Imagine, has over 1,400 medical centres including 26 medical imaging centres. SuperSonic Imagine’s ShearWave Elastography (SWE) is already well known and the benefits of this technology, which has been used for years in Israel, are much appreciated and recognised by the medical community.

We are very honored that Clalit has chosen to put their faith in us once again and for this we thank them. Since 2015, we’ve had a close and trusting working relationship through our exclusive distributor Inframed and it is almost natural that our very innovative solution has found its place in this network at the forefront of medical technology innovation,” explained Michèle Lesieur, CEO of SuperSonic Imagine.

We aim to offer the best medical service to our population. When it comes to ultrasound, MACH 30 is at the forefront of image quality or innovative user interface, as it offers the most validated ShearWave Elastography (SWE) for the liver. SWE allows us to assess the degree of liver fibrosis and cirrhosis, and therefore limits the use of invasive liver biopsy,” stated the Dr. Ziv Neeman, Chairman of the Medical Imaging Institute at Haemek Hospital owned by Clalit.





Aixplorer MACH 30, a new ultrasound concept: New user interface and new-generation UltraFast™ imaging

The unique SonicPad® concept is an innovative and intuitive device which revolutionises the conventional ultrasound approach. The SonicPad® improves the radiologist’s workflow by reducing up to 77% of the user’s movements and up to 32% of the time for the exam. The SonicPad® means the user can focus on the images rather than operating the ultrasound system.

The new Aixplorer MACH 30 ultrasound system introduces new-generation UltraFast™ imaging, enhancing the full range of imaging modes such as ShearWave PLUS, Doppler UltraFast, Angio PL.U.S and TriVu for superior diagnostic performance. The open and upgradeable software architecture of Aixplorer MACH 30, will be enabled to integrate, in the near future, deep learning and artificial intelligence to support the radiologist in their diagnostic approach.

Presented at numerous scientific congresses in France (JFR) and the United States (AASLD, RSNA) in 2018, the Aixplorer MACH 30 ultrasound system has been extremely well received by the scientific community. It will be presented again at the European Congress of Radiology to be held in Vienna, Austria, from 27 February to 3 March 2019.

Learn more about Aixplorer MACH 30 at

About SuperSonic Imagine

SuperSonic Imagine is a medical technology company (Medtech) specialized in ultrasound imaging. The company designs, develops and markets an ultrasound platform whose exclusive ultrafast technology (UltraFast™) has given rise to new imaging methods, which have now become standards in the non-invasive care path for the characterization of breast, liver or prostate diseases. The first innovative mode UltraFast™ is ShearWave® elastography (SWE™), which allows doctors to instantly visualize and analyze tissue hardness, which is critical information for the diagnosis of many pathologies. To date, more than 600 publications have validated the benefits of its technologies. The latest addition to the Aixplorer® range, Aixplorer MACH® 30 introduces a new generation of imaging UltraFast™ allowing the optimization of all innovative imaging modes: ShearWave PLUS, UltraFast Doppler, Angio PL.U.S, TriVu. With more than 2,300 ultrasound platforms installed worldwide, SuperSonic Imagine is present in more than 80 countries and its main markets are China, the United States and France. In 2018, the company generated revenues of €24.6 million. SuperSonic Imagine is a company listed on Euronext (symbol: SSI).

For more information, visit

Contacts

SuperSonic Imagine

Marketing & Communication

Emmanuelle Vella



27



FP2COM

Relations Médias - EU

Florence Portejoie



83
NewCap

Investor Relations – EU

Thomas Grojean / Nicolas Merigeau



55



 
EN
24/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SuperSonic Imagine SA

 PRESS RELEASE

SuperSonic Imagine annonce la clôture du contrat de liquidité conclu a...

AIX-EN-PROVENCE, France--(BUSINESS WIRE)-- Regulatory News: SuperSonic Imagine (Euronext Growth : ALSSI, FR0010526814, éligible PEA-PME, la « Société »), société spécialisée dans l’imagerie médicale par ultrasons (échographie), annonce la clôture du contrat de liquidité conclu avec Gilbert Dupont Suite l’Offre Publique d’Achat de la société HOLOGIC HUB Ltd sur les actions SUPERSONIC IMAGINE, la société SUPERSONIC IMAGINE met fin au contrat de liquidité conclu le 17 avril 2017 avec la société GILBERT DUPONT. Cette résiliation a pris effet le 28 mai 2021 au soir. A cette date, les moyens suiv...

 PRESS RELEASE

SuperSonic Imagine : Information mensuelle relative au nombre total de...

AIX-EN-PROVENCE, France--(BUSINESS WIRE)-- Regulatory News: SuperSonic Imagine (Paris:ALSSI): Place de cotation: Euronext Growth Compartiment: Compartiment C Code ISIN: FR0010526814 Site web : Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total brut (1) Total net (2) 31 mai 2021 24 365 850 24 365 850 24 265 118 (1) Le nombre de droits de vote bruts (ou droits de vote “théoriques”) sert de base de calcul pour les franchissements de seuil. Conformément à l’article 223-11 du Règlement Général de l’AMF, ce nombre est ...

 PRESS RELEASE

COMMUNIQUE DE PRESSE DU 26 MAI 2021 RELATIF A LA MISE EN ŒUVRE PAR HOL...

MANCHESTER, Royaume-Uni--(BUSINESS WIRE)-- Regulatory News: Ce communiqué ne constitue pas une offre d’acquérir des titres Ne pas publier, diffuser ou distribuer aux Etats-Unis ou dans tout autre pays que la France COMMUNIQUE DE PRESSE DU 26 MAI 2021 RELATIF A LA MISE EN ŒUVRE PAR HOLOGIC HUB LTD. DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ Montant de l’indemnisation : 1,50 euro par action SuperSonic Imagine (net de tous frais) Le présent communiqué est établi et diffusé par la société Hologic Hub Ltd. en application de l’article 237-3 III du Règlement général de l’Autorit...

 PRESS RELEASE

Résultat de l’offre publique d’achat simplifiée initiée par Hologic Hu...

MANCHESTER, Royaume-Uni & AIX-EN-PROVENCE, France--(BUSINESS WIRE)-- Regulatory News: Conformément à l’avis publié ce jour par l’Autorité des marchés financiers (avis AMF D&I n°221C0973), 3 672 579 actions SuperSonic Imagine (Paris:ALSSI) ont été présentées par les actionnaires de SuperSonic Imagine à l’offre publique d’achat simplifiée initiée par Hologic Hub Ltd. libellée au prix de 1,50 euro par action, ouverte du 15 au 30 avril 2021 (inclus) (l’ « Offre »). Hologic Hub Ltd. détiendra, à l’issue des opérations de règlement-livraison, 23 173 992 actions SuperSonic Imagine et autant de droi...

 PRESS RELEASE

Suspension du cours des actions de SuperSonic Imagine sur Euronext Gro...

AIX-EN-PROVENCE, France--(BUSINESS WIRE)-- Regulatory News: SuperSonic Imagine (Euronext Growth : ALSSI, FR0010526814, éligible PEA-PME), société spécialisée dans l’imagerie médicale par ultrasons (échographie) (la « Société »), informe ses actionnaires que la Société a demandé à Euronext Growth Paris la suspension de la cotation de son titre (ALSSI, FR0010526814) à compter de 9h00 ce jour (soit le mardi 4 mai 2021, à l’ouverture de la bourse de Paris), dans l’attente de la publication d’un communiqué de presse annonçant les résultats de l’offre publique d’achat simplifiée initiée par Hologic...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch